Oligodendroglioma: Advances in Molecular Mechanisms and Immunotherapeutic Strategies
Oligodendroglioma is a central nervous system tumor defined by <i>IDH1/2</i> mutations and 1p/19q co-deletion. Current management involves maximal resection followed by radiotherapy/chemotherapy, yielding a 20-year survival rate of 37% for grade 3 tumors according to the WHO 2021 classif...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1133 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|